Screening for Mupirocin Resistance in Staphylococcus
نویسندگان
چکیده
منابع مشابه
Prevalence of mupirocin resistance in Staphylococcus pseudintermedius.
In the United States, veterinary use of mupirocin is primarily limited to the treatment of canine pyoderma caused by methicillin-resistant Staphylococcus pseudintermedius (MRSP). In this study, only 1 of 581 S. pseudintermedius isolates tested was resistant to mupirocin and carried the high-level mupirocin resistance gene, ileS2, on a plasmid.
متن کاملMupirocin Resistance in Methicillin Resistant Staphylococcus Aureus
Mupirocin is the topical antimicrobial agent which is used for the treatment of methicillin resistant Staphylococcus aureus (MRSA). However the prevalence of mupirocin resistance in MRSA has increased with the extensive and widespread use of this agent in hospital settings. The present study was attempted to evaluate the low level and high level resistance to mupirocin in MRSA isolates by diffe...
متن کاملMupirocin Resistance in Methicillin Resistant Staphylococcus Aureus
Mupirocin is the topical antimicrobial agent which is used for the treatment of methicillin resistant Staphylococcus aureus (MRSA). However the prevalence of mupirocin resistance in MRSA has increased with the extensive and widespread use of this agent in hospital settings. The present study was attempted to evaluate the low level and high level resistance to mupirocin in MRSA isolates by diffe...
متن کاملMupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population.
We investigated the proportion of methicillin-resistant Staphylococcus aureus (MRSA) isolates from pediatric patients demonstrating mupirocin resistance related to mupirocin use at our institution. No mupirocin resistance was found in 98% of isolates, whereas mupirocin prescriptions increased by 110%. Resistance rates remained low despite the increasing use of mupirocin.
متن کاملLow concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.
We describe a patient with methicillin-resistant Staphylococcus aureus (MRSA) colonizing the pharynx. The MIC of mupirocin was 0.25 microg/ml before treatment and increased after treatment to 8 microg/ml. Using pulsed-field gel electrophoresis, we confirmed that the genotypes of MRSA that colonized the pharynx before and after the use of mupirocin were identical. We measured the delivery of mup...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
سال: 2015
ISSN: 2249-782X
DOI: 10.7860/jcdr/2015/15230.6678